Home

Stewards of critical care

Innoviva Specialty Therapeutics develops and delivers innovative therapies for patients in critical care and infectious disease

FOCUS

Addressing urgent needs

We are uniquely positioned to combat serious conditions and advance innovative treatment options in areas of high unmet need

A hand.

Critical Care

Innovative solutions for patients with serious, life-threatening conditions

Infectious Diseases

Therapies for emerging illnesses caused by drug-resistant microorganisms

Global Mission

Advancing solutions for the most critical and urgent infections identified by the world's leading public health organizations

Our products

GIAPREZA®

(angiotensin II)

A vasoconstrictor to increase blood pressure in adults with septic or other distributive shock

In partnership with Created with Sketch.

VISIT GIAPREZA.COM

XERAVA®

(eravacycline)

An antibiotic indicated for the treatment of complicated intra-abdominal infection caused by susceptible microorganisms

VISIT XERAVA.COM

XACDURO®

(sulbactam for injection; durlobactam for injection), co-packaged for intravenous use

For the treatment of hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter

VISIT XACDURO.COM

Development pipeline

Product

Phase 1

Phase 2

Phase 3

Review

Approval

ZOLIFLODACIN

Uncomplicated gonorrhea

Company

An enduring influence

A growing and diversified biopharmaceutical company, we are building a culture dedicated to delivering products that save lives

Leadership

Led by a mission-driven team that blends rigorous medical science with the latest advances in pharmaceutical innovation

Learn More

Careers

Join a team where all colleagues can do their best work while making a lasting impact

Learn More